Trial intelligence / Profile preview

Evaluation of the effect of melatonin in sepsis

IRCT20171104037228N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of melatonin in sepsis, sponsored by Tehran University of Medical Sciences. Started Jan 2018; status: completed.

02

Drugs

melatonin
03

Conditions

sepsis

Beyond the preview

Go deeper on IRCT20171104037228N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171104037228N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call